4//SEC Filing
Pizzo Philip A. 4
Accession 0000899243-21-024969
CIK 0001629137other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:15 PM ET
Size
18.9 KB
Accession
0000899243-21-024969
Insider Transaction Report
Form 4
Pizzo Philip A.
Director
Transactions
- Sale
Common Stock
2021-06-18$36.54/sh−1,065$38,915→ 6,772 total - Exercise/Conversion
Restricted Stock Units
2021-06-17−3,037→ 0 totalFrom: 2021-06-17→ Common Stock (3,037 underlying) - Award
Stock Option (Right to Buy)
2021-06-17+5,600→ 5,600 totalExercise: $37.09Exp: 2031-06-16→ Common Stock (5,600 underlying) - Award
Restricted Stock Units
2021-06-17+3,600→ 3,600 total→ Common Stock (3,600 underlying) - Exercise/Conversion
Common Stock
2021-06-17+3,037→ 7,837 total
Footnotes (5)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 7, 2021 to cover the Reporting Person's tax obligations in connection with the vesting of 3,037 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The RSUs vested in a single installment on June 17, 2021.
- [F4]The shares subject to this option shall vest and become exercisable in equal monthly installments over a period of 12 months following June 17, 2021 for 11 months and the remaining 1/12th on the earlier of (i) June 17, 2022 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
- [F5]The shares of Common Stock underlying the RSUs vest in a single installment on the earlier of (i) June 17, 2022 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001574286
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:15 PM ET
- Size
- 18.9 KB